Asymchem Laboratories (Tianjin) Co., Ltd. logo

Asymchem Laboratories (Tianjin) Co., Ltd. (002821)

Market Closed
10 Aug, 06:57
XSHE XSHE
¥
176. 00
+3.74
+2.1711%
¥
34.14B Market Cap
- P/E Ratio
4.4% Div Yield
23.28M Volume
- Eps
¥ 172.26
Previous Close
Add Transaction
Day Range
156.5 188
Year Range
88.46 200
Want to track 002821 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002821 closed today higher at ¥176, an increase of 2.1711% from yesterday's close, completing a monthly increase of 10.7754% or ¥17.12. Over the past 12 months, 002821 stock gained 88.8412%.
002821 pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next estimated payment will be in In 10 months on Jun 26, 2027 for a total of ¥1.3.
The last earnings report, released on Mar 31, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.4449%, based on the last three reports.
Asymchem Laboratories (Tianjin) Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jul 21, 2022.
The company's stock is traded on one exchange.

002821 Chart

People also search for

Aier Eye Hospital Group Co. Ltd.
¥ 9.07
+2.8345%
Haisco Pharmaceutical Group Co., Ltd.
¥ 70.28
-1.8436%
Shannon Semiconductor Tech Inc.
¥ 156.64
-1.2918%
Sichuan Kelun Pharmaceutical Co., Ltd.
¥ 46.41
+2.1347%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
¥ 27.62
-1.7432%

Asymchem Laboratories (Tianjin) Co., Ltd. (002821) FAQ

What is the stock price today?

The current price is ¥176.00.

On which exchange is it traded?

Asymchem Laboratories (Tianjin) Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002821.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.4%.

What is its market cap?

As of today, the market cap is 34.14B.

Has Asymchem Laboratories (Tianjin) Co., Ltd. ever had a stock split?

Asymchem Laboratories (Tianjin) Co., Ltd. had 2 splits and the recent split was on Jul 21, 2022.

Asymchem Laboratories (Tianjin) Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Dr. Hao Hong Ph.D. CEO
XSHE Exchange
CNE100002BZ6 ISIN
CN Country
9,595 Employees
26 Jun 2026 Last Dividend
14 Jun 2017 Last Split
- IPO Date

Overview

Asymchem Laboratories (Tianjin) Co., Ltd. is a prominent player in the contract development and manufacturing sector, providing comprehensive services that foster the innovation and commercial application of pharmaceutical technology not just in Mainland China, but on an international scale. Established in 1999 and headquartered in Tianjin, China, Asymchem has solidified its reputation by offering a wide range of solutions to pharmaceutical and biotech companies. These solutions encompass various stages of drug development and production, from early clinical to commercial stages. Asymchem's commitment to excellence is evident in their provision of research and development, as well as cGMP (current Good Manufacturing Practices) production services for advanced intermediates, active pharmaceutical ingredients (APIs), and formulations. Furthermore, the company extends its services to include clinical research, highlighting its role as an integral partner in the pharmaceutical industry's R&D and production spectrum.

Products and Services

Asymchem Laboratories offers a comprehensive suite of products and services designed to meet the multifaceted needs of the pharmaceutical and biotechnology sectors, including:

  • Research and Development: Focused on the early stages of drug development, Asymchem's research and development services aim to bring innovative pharmaceutical solutions from concept to reality, ensuring efficacy, safety, and regulatory compliance.
  • cGMP Production: The company's cGMP production capabilities cover a wide range of pharmaceutical needs, from advanced intermediates and active pharmaceutical ingredients (APIs) to formulations. Adhering to the current Good Manufacturing Practices ensures that all products meet the highest standards of quality and safety.
  • Clinical Research Services: Asymchem extends its expertise to include clinical research services, underscoring its commitment to supporting the advancement and validation of pharmaceutical products through rigorous clinical trials.
  • Pharmaceutical Analysis and Testing Services: To complement its manufacturing and research services, Asymchem offers extensive analysis and testing services, providing critical insights into the composition, potency, and purity of pharmaceutical products.
  • Information Technology Services: Recognizing the importance of technology in modern pharmaceutical development, Asymchem incorporates IT services to enhance its research, development, and manufacturing processes, ensuring efficiency and innovation.
  • Pharmaceutical Science and Technology Development Activities: The company is actively engaged in activities aimed at advancing pharmaceutical science and technology, demonstrating its dedication to pushing the boundaries of what is possible in medication development.
  • Sale, Wholesale, and Retail of Drugs: Beyond development and manufacturing, Asymchem also takes part in the distribution of pharmaceutical products, catering to a broad market through sales, wholesale, and retail channels.
  • Manufacture, Development, and Sale of Medicine Raw Materials and Relevant Products: The company is not just limited to finished pharmaceutical products but is also involved in the manufacture and sale of raw materials and other relevant products, showcasing its versatility and comprehensive approach to the pharmaceutical supply chain.
  • Manufacture of Chemical Products: In addition to pharmaceuticals, Asymchem engages in the manufacture of a range of chemical products, indicating its broad capabilities and commitment to leveraging its chemical manufacturing expertise.
  • Technology Development Activities: Central to Asymchem's operations are its ongoing technology development activities, through which the company seeks to innovate and improve upon its processes and products continuously.

Contact Information

Address: No. 6 Dongting 3rd Street, Tianjin, China, 300457
Phone: 86 22 6638 9560